Foscarnet: Difference between revisions

Jump to navigation Jump to search
ShiSheng (talk | contribs)
No edit summary
ShiSheng (talk | contribs)
No edit summary
Line 1: Line 1:
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
__NOTOC__
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Foscarnet|{{fontcolor|#6C7B8B|Foscarnet}}]]'''''
{{XXXXX}}
|-
{{CMG}}
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | FOSCAVIR<sup>®</sup> FDA Package Insert
 
|-
==Overview==
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Foscarnet description|Description]]
'''Foscarnet''' is the [[conjugate base]] of the [[chemical compound]] with the [[chemical formula|formula]] HO<sub>2</sub>CPO<sub>3</sub>H<sub>2</sub>.  This [[phosphonic acid]] derivative is (marketed by [[AstraZeneca]] as foscarnet [[sodium]] under the trade name Foscavir®) is an [[antiviral]][[medication]] used to treat [[herpes viruses]], including [[cytomegalovirus]] (CMV) and [[herpes simplex]] viruses types 1 and 2 (HSV-1 and HSV-2).  It is particularly used to treat [[CMV retinitis]].
|-
==Category==
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Foscarnet clinical pharmacology|Clinical Pharmacology]]
Antiviral
|-
 
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Foscarnet microbiology|Microbiology]]
==US Brand Names==
|-
FOSCAVIR<sup>®</sup>
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Foscarnet indications and usage|Indications and Usage]]
 
|-
 
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Foscarnet contraindications|Contraindications]]
==FDA Package Insert==
|-
 
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Foscarnet warnings and precautions|Warnings and Precautions]]
'''  [[XXXXX description|Description]]'''
|-
'''| [[XXXXX clinical pharmacology|Clinical Pharmacology]]'''
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Foscarnet adverse reactions|Adverse Reactions]]
'''| [[XXXXX microbiology|Microbiology]]'''
|-
'''| [[XXXXX indications and usage|Indications and Usage]]'''
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Foscarnet drug interactions|Drug Interactions]]
'''| [[XXXXX contraindications|Contraindications]]'''
|-
'''| [[XXXXX warnings and precautions|Warnings and Precautions]]'''
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Foscarnet overdosage|Overdosage]]
'''| [[XXXXX adverse reactions|Adverse Reactions]]'''
|-
'''| [[XXXXX drug interactions|Drug Interactions]]'''
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Foscarnet clinical studies|Clinical Studies]]
'''| [[XXXXX overdosage|Overdosage]]'''
|-
'''| [[XXXXX clinical studies|Clinical Studies]]'''
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Foscarnet dosage and administration|Dosage and Administration]]
'''| [[XXXXX dosage and administration|Dosage and Administration]]'''
|-
'''| [[XXXXX how supplied|How Supplied]]'''
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Foscarnet how supplied|How Supplied]]
'''| [[XXXXX labels and packages|Labels and Packages]]'''
|-
 
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Foscarnet labels and packages|Labels and Packages]]
==Mechanism of Action==
|-
 
|}
 
 
==References==
 
{{Reflist|2}}
 
[[Category:Antibiotics]]
[[Category:Wikinfect]]

Revision as of 00:36, 5 January 2014


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Foscarnet is the conjugate base of the chemical compound with the formula HO2CPO3H2. This phosphonic acid derivative is (marketed by AstraZeneca as foscarnet sodium under the trade name Foscavir®) is an antiviralmedication used to treat herpes viruses, including cytomegalovirus (CMV) and herpes simplex viruses types 1 and 2 (HSV-1 and HSV-2). It is particularly used to treat CMV retinitis.

Category

Antiviral

US Brand Names

FOSCAVIR®


FDA Package Insert

Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages

Mechanism of Action

References